These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 9796640)

  • 1. CYP17 genotype and breast cancer risk.
    Weston A; Pan CF; Bleiweiss IJ; Ksieski HB; Roy N; Maloney N; Wolff MS
    Cancer Epidemiol Biomarkers Prev; 1998 Oct; 7(10):941-4. PubMed ID: 9796640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CYP17 genetic polymorphism, breast cancer, and breast cancer risk factors.
    Ambrosone CB; Moysich KB; Furberg H; Freudenheim JL; Bowman ED; Ahmed S; Graham S; Vena JE; Shields PG
    Breast Cancer Res; 2003; 5(2):R45-51. PubMed ID: 12631398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between CYP17 polymorphisms and the development of breast cancer.
    Helzlsouer KJ; Huang HY; Strickland PT; Hoffman S; Alberg AJ; Comstock GW; Bell DA
    Cancer Epidemiol Biomarkers Prev; 1998 Oct; 7(10):945-9. PubMed ID: 9796641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steroid metabolism gene CYP17 polymorphism and the development of breast cancer.
    Mitrunen K; Jourenkova N; Kataja V; Eskelinen M; Kosma VM; Benhamou S; Vainio H; Uusitupa M; Hirvonen A
    Cancer Epidemiol Biomarkers Prev; 2000 Dec; 9(12):1343-8. PubMed ID: 11142420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CYP17 5'-UTR MspA1 polymorphism and the risk of premenopausal breast cancer in a German population-based case-control study.
    Verla-Tebit E; Wang-Gohrke S; Chang-Claude J
    Breast Cancer Res; 2005; 7(4):R455-64. PubMed ID: 15987450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate cancer risk and polymorphism in 17 hydroxylase (CYP17) and steroid reductase (SRD5A2).
    Lunn RM; Bell DA; Mohler JL; Taylor JA
    Carcinogenesis; 1999 Sep; 20(9):1727-31. PubMed ID: 10469617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic polymorphism of CYP17 and breast cancer risk in Korean women.
    Shin MH; Lee KM; Yang JH; Nam SJ; Kim JW; Yoo KY; Park SK; Noh DY; Ahn SH; Kim B; Kang D
    Exp Mol Med; 2005 Feb; 37(1):11-7. PubMed ID: 15761247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A polymorphism in CYP17 and endometrial cancer risk.
    Haiman CA; Hankinson SE; Colditz GA; Hunter DJ; De Vivo I
    Cancer Res; 2001 May; 61(10):3955-60. PubMed ID: 11358812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between a polymorphism in CYP17 with plasma hormone levels and breast cancer.
    Haiman CA; Hankinson SE; Spiegelman D; Colditz GA; Willett WC; Speizer FE; Kelsey KT; Hunter DJ
    Cancer Res; 1999 Mar; 59(5):1015-20. PubMed ID: 10070957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The CYP17 MspA1 polymorphism and breast cancer risk: a meta-analysis.
    Ye Z; Parry JM
    Mutagenesis; 2002 Mar; 17(2):119-26. PubMed ID: 11880540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A polymorphism in the CYP17 gene increases the risk of breast cancer.
    Feigelson HS; Coetzee GA; Kolonel LN; Ross RK; Henderson BE
    Cancer Res; 1997 Mar; 57(6):1063-5. PubMed ID: 9067272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: a multigenic study on cancer susceptibility.
    Huang CS; Chern HD; Chang KJ; Cheng CW; Hsu SM; Shen CY
    Cancer Res; 1999 Oct; 59(19):4870-5. PubMed ID: 10519398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CYP17 gene polymorphism and its association with high-risk north Indian breast cancer patients.
    Chakraborty A; Murthy NS; Chintamani C; Bhatnagar D; Mohil RS; Sharma PC; Saxena S
    J Hum Genet; 2007; 52(2):159-165. PubMed ID: 17235448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of genetic polymorphisms of ER-alpha and the estradiol-synthesizing enzyme genes CYP17 and CYP19 with breast cancer risk in Chinese women.
    Zhang L; Gu L; Qian B; Hao X; Zhang W; Wei Q; Chen K
    Breast Cancer Res Treat; 2009 Mar; 114(2):327-38. PubMed ID: 18629629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased risk of prostate cancer and benign prostatic hyperplasia associated with a CYP17 gene polymorphism with a gene dosage effect.
    Habuchi T; Liqing Z; Suzuki T; Sasaki R; Tsuchiya N; Tachiki H; Shimoda N; Satoh S; Sato K; Kakehi Y; Kamoto T; Ogawa O; Kato T
    Cancer Res; 2000 Oct; 60(20):5710-3. PubMed ID: 11059764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CYP17 gene polymorphism in relation to breast cancer risk: a case-control study.
    Einarsdóttir K; Rylander-Rudqvist T; Humphreys K; Ahlberg S; Jonasdottir G; Weiderpass E; Chia KS; Ingelman-Sundberg M; Persson I; Liu J; Hall P; Wedrén S
    Breast Cancer Res; 2005; 7(6):R890-6. PubMed ID: 16280037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Four polymorphisms in cytochrome P450 1A1 (CYP1A1) gene and breast cancer risk: a meta-analysis.
    Sergentanis TN; Economopoulos KP
    Breast Cancer Res Treat; 2010 Jul; 122(2):459-69. PubMed ID: 20035380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CYP17 genetic polymorphism, breast cancer, and breast cancer risk factors: Australian Breast Cancer Family Study.
    Chang JH; Gertig DM; Chen X; Dite GS; Jenkins MA; Milne RL; Southey MC; McCredie MR; Giles GG; Chenevix-Trench G; Hopper JL; Spurdle AB
    Breast Cancer Res; 2005; 7(4):R513-21. PubMed ID: 15987458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CYP17 and SULT1A1 gene polymorphisms in Indian breast cancer.
    Chacko P; Rajan B; Mathew BS; Joseph T; Pillai MR
    Breast Cancer; 2004; 11(4):380-8. PubMed ID: 15604994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyp17 promoter variant associated with prostate cancer aggressiveness in African Americans.
    Kittles RA; Panguluri RK; Chen W; Massac A; Ahaghotu C; Jackson A; Ukoli F; Adams-Campbell L; Isaacs W; Dunston GM
    Cancer Epidemiol Biomarkers Prev; 2001 Sep; 10(9):943-7. PubMed ID: 11535545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.